Want to join the conversation?
$SYMC FY15 10-K: Net cash provided by operating activities was $1.31Bil vs. $1.28Bil in FY14. Net cash used in investing activities was $1.15Bil vs. $583MM in FY14. Net cash used in financing activities was $811MM vs. $1.71Bil in FY14. Sequentially, cash and cash equivalents decreased $833MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.